Match the Drug Names in Column 1 with Their Drug

question 16

Short Answer

Match the drug names in Column 1 with their drug category in Column 2.
A)over-the-counter iron supplement
B)tissue plasminogen activator drug
C)erythropoietin-like drug for anemia
D)factor Xa inhibitor drug
E)platelet aggregation inhibitor drug
F)thrombin inhibitor drug
G)warfarin
H)low molecular weight heparin drug
I)drug used to treat hemophilia
J)combination aspirin and platelet aggregation inhibitor drug
1)clopidogrel (Plavix)
2)ferrous sulfate
3)Aggrenox
4)bivalirudin (Angiomax)
5)Coumadin
6)enoxaparin (Lovenox)
7)epoetin alfa (Epogen,Procrit)
8)fondaparinux (Arixtra)
9)reteplase (Retavase)
"10)factor VIIa (NovoSeven)

• A)over-the-counter iron supplement
• B)tissue plasminogen activator drug
• C)erythropoietin-like drug for anemia
• D)factor Xa inhibitor drug
• E)platelet aggregation inhibitor drug
• F)thrombin inhibitor drug
• G)warfarin
• H)low molecular weight heparin drug
• I)drug used to treat hemophilia
• J)combination aspirin and platelet aggregation inhibitor drug
• 1)clopidogrel (Plavix)
• 2)ferrous sulfate
• 3)Aggrenox
• 4)bivalirudin (Angiomax)
• 5)Coumadin
• 6)enoxaparin (Lovenox)
• 7)epoetin alfa (Epogen,Procrit)
• 8)fondaparinux (Arixtra)
• 9)reteplase (Retavase)
• "10)factor VIIa (NovoSeven)

---

Definitions:

Excess Consideration

The amount paid over and above the fair value of net assets acquired in a business acquisition.

Goodwill

An intangible asset that arises when a business is acquired for more than the sum of its identifiable net assets.

Equity Income

Income earned by an investor from an investment in the stock of a company, typically through dividends and the investment's appreciation in value.

Annual Review

A periodic evaluation process, often yearly, used to assess an individual's or organization's performance, financial state, or the status of a certain project.